Processa Pharmaceuticals(PCSA) - 2018 Q4 - Annual Report

FORM 10-K [X] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [ ] Transitional Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 333-184948 Processa Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware 45-1539785 (State or other jurisdiction (IRS Employer of incorporation) Identific ...